Ask AI
EBC Care

CE / CME

Advancing the Care of Patients With High-Risk HR-Positive/HER2-Negative Early Breast Cancer

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Pharmacists: 0.50 contact hour (0.05 CEUs)

Nurse Practitioners/Nurses: 0.50 Nursing contact hour

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Released: October 15, 2025

Expiration: April 14, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

A 58-year-old postmenopausal woman is diagnosed with ER+/PgR+/HER2- ILC, grade 3, with no BRCA mutation. She undergoes a lumpectomy with SLNB that shows a 4-cm ILC with 2/3 positive nodes (T2N1). Her Oncotype DX recurrence score is 26. She completed TC x 4 cycles, followed by adjuvant radiation and is returning to discuss continued adjuvant treatment.

In addition to extended-duration adjuvant endocrine therapy, what additional systemic therapy would be an appropriate treatment for this patient?